ABSTRACT
Soil color is commonly used as an indicator to classify soil and identify its properties. However, color-based soil assessments are susceptible to variations in light conditions and the subjectivity of visual evaluations. This study proposes a novel method of calibrating digital images of soil, regardless of lighting conditions, to ensure accurate identification. Two different color space models, RGB and CIELAB, were assessed in terms of their potential utility in calibrating changes to soil color in digital images. The latter system was determined to be suitable, as a result of its ability to accurately reflect illuminance and color temperature. Linear regression equations relating soil color and light conditions were developed based on digital images of four different types of soil samples, each photographed under 15 different light conditions. The proposed method can be applied to calibrate variations in the soil color obtained by digital images, thus allowing for more standardized, objective, and accurate classification and evaluation of soil based on its color.
Subject(s)
Lighting , Soil , Color , Calibration , TemperatureABSTRACT
Neurological disorders represent a substantial healthcare burden worldwide due to population aging. Acorus gramineus Solander (AG) and Acorus tatarinowii Schott (AT), whose major component is asarone, have been shown to be effective in neurological disorders. This review summarized current information from preclinical and clinical studies regarding the effects of extracts and active components of AG and AT (e.g., α-asarone and ß-asarone) on neurological disorders and biomedical targets, as well as the mechanisms involved. Databases, including PubMed, Embase, and RISS, were searched using the following keywords: asarone, AG, AT, and neurological disorders, including Alzheimer's disease, Parkinson's disease, depression and anxiety, epilepsy, and stroke. Meta-analyses and reviews were excluded. A total of 873 studies were collected. A total of 89 studies were selected after eliminating studies that did not meet the inclusion criteria. Research on neurological disorders widely reported that extracts or active components of AG and AT showed therapeutic efficacy in treating neurological disorders. These components also possessed a wide array of neuroprotective effects, including reduction of pathogenic protein aggregates, antiapoptotic activity, modulation of autophagy, anti-inflammatory and antioxidant activities, regulation of neurotransmitters, activation of neurogenesis, and stimulation of neurotrophic factors. Most of the included studies were preclinical studies that used in vitro and in vivo models, and only a few clinical studies have been performed. Therefore, this review summarizes the current knowledge on AG and AT therapeutic effects as a basis for further clinical studies, and clinical trials are required before these findings can be applied to human neurological disorders.
